Insight Molecular Diagnostics INC. (IMDX) SEC Filings — 2025
18 SEC filings for Insight Molecular Diagnostics INC. (IMDX) in 2025.
Filings
- IMDX Revenue Soars 638% Amidst Continued Losses, Strategic Rebrand — 10-Q · Nov 10, 2025
- Insight Molecular Diagnostics Files 8-K — 8-K · Nov 10, 2025
- Insight Molecular Diagnostics Inc. Files 8-K on Officer/Director Changes — 8-K · Oct 2, 2025
- Insight Molecular Diagnostics Inc. Announces Board and Officer Changes — 8-K · Sep 19, 2025
- Insight Molecular Diagnostics Files 8-K — 8-K · Aug 11, 2025
- IMDX Q2 Loss Widens to $10.9M Amid Revenue Dip — 10-Q · Aug 11, 2025
- Insight Molecular Diagnostics Inc. Files 8-K on Shareholder Vote — 8-K · Jul 2, 2025
- Oncocyte Corp. Files 8-K with Corporate Updates — 8-K · Jun 17, 2025
- Oncocyte Corp Files Definitive Proxy Statement — DEF 14A · May 14, 2025
- Oncocyte Corp Files 8-K on Financials — 8-K · May 12, 2025
- Oncocyte Corp Files 10-Q for Q1 2025 — 10-Q · May 12, 2025
- Oncocyte Corp Changes Independent Accountant — 8-K · Apr 17, 2025
- Oncocyte Corp Files S-1 for Securities Registration — S-1 · Mar 28, 2025
- Oncocyte Corp Files 8-K on Financials — 8-K · Mar 24, 2025
- Oncocyte Corp Files 2024 10-K, Details Chronix Merger — 10-K · Mar 24, 2025
- Oncocyte Corp Appoints New Directors, Updates Executive Contracts — 8-K · Mar 10, 2025
- Oncocyte Corp Files 8-K: Agreements, Sales, and Disclosures — 8-K · Feb 10, 2025
- Oncocyte Corp Enters Material Definitive Agreement — 8-K · Jan 8, 2025